TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split
29. November 2024 16:25 ET
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split
TransCode Therapeutics, Inc. Announces $8 Million Private Placement
27. November 2024 07:00 ET
|
TransCode Therapeutics, Inc.
TransCode Therapeutics, Inc. Announces $8 Million Private Placement
TransCode Therapeutics Announces 1-for-33 Reverse Stock Split
25. November 2024 07:00 ET
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Announces 1-for-33 Reverse Stock Split
TransCode Therapeutics Open Letter to Shareholders
12. November 2024 07:00 ET
|
TransCode Therapeutics, Inc.
Open Letter to Shareholders
TransCode Therapeutics Announces Nasdaq Extension to Regain Compliance
05. November 2024 07:00 ET
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Announces Nasdaq Extension to Re-gain Compliance
TransCode Therapeutics Announces Safety Review Committee Approval of Second Cohort Opening in Phase 1 TTX-MC138 Clinical Trial Following Favorable Review of Cohort 1 Safety Data
23. Oktober 2024 07:00 ET
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Announces Safety Review Committee Approval of Second Cohort Opening in Phase 1 TTX-MC138 Clinical Trial Following Favorable Review o
TransCode Therapeutics Completes Initial Dosing of First Cohort in Phase 1 Clinical Trial with TTX-MC138, a microRNA-Targeted Technology
10. Oktober 2024 07:00 ET
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Completes Initial Dosing of First Co-hort in Phase 1 Clinical Trial with TTX-MC138, a microRNA-Targeted Technology
TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate
17. September 2024 07:00 ET
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate
Marrying Form and Function, PrismHR Unveils New Unified Employee Experience (UEX)
12. Oktober 2023 15:13 ET
|
PrismHR
PrismHR Unveils New Unified Employee Experience (UEX)
Kevin Andrews Named President of PrismHR
05. Oktober 2023 07:00 ET
|
PrismHR
Kevin Andrews Named President of PrismHR